BR0015770A - Compostos bicìclicos análogos de vitamina d, uso de um composto, composição farmacêutica, composição cosmética e uso de uma composição cosmética - Google Patents
Compostos bicìclicos análogos de vitamina d, uso de um composto, composição farmacêutica, composição cosmética e uso de uma composição cosméticaInfo
- Publication number
- BR0015770A BR0015770A BR0015770-8A BR0015770A BR0015770A BR 0015770 A BR0015770 A BR 0015770A BR 0015770 A BR0015770 A BR 0015770A BR 0015770 A BR0015770 A BR 0015770A
- Authority
- BR
- Brazil
- Prior art keywords
- cosmetic composition
- composition
- vitamin
- compound
- cosmetic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/08—Antiseborrheics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Transplantation (AREA)
- Ophthalmology & Optometry (AREA)
- Neurosurgery (AREA)
- Nutrition Science (AREA)
- Molecular Biology (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9914783A FR2801307B1 (fr) | 1999-11-24 | 1999-11-24 | Analogues de la vitamine d |
PCT/FR2000/003250 WO2001038320A1 (fr) | 1999-11-24 | 2000-11-22 | Analogues de la vitamine d |
Publications (2)
Publication Number | Publication Date |
---|---|
BR0015770A true BR0015770A (pt) | 2002-08-06 |
BR0015770B1 BR0015770B1 (pt) | 2013-07-30 |
Family
ID=9552485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0015770-8B1A BR0015770B1 (pt) | 1999-11-24 | 2000-11-22 | compostos bicíclicos análogos de vitamina d, uso de um composto, composição farmacêutica e composição cosmética |
Country Status (20)
Country | Link |
---|---|
US (1) | US6706725B1 (pt) |
EP (1) | EP1235824B1 (pt) |
JP (1) | JP4003210B2 (pt) |
KR (1) | KR100554555B1 (pt) |
CN (1) | CN1214022C (pt) |
AR (1) | AR043280A1 (pt) |
AT (1) | ATE267190T1 (pt) |
AU (1) | AU767427B2 (pt) |
BR (1) | BR0015770B1 (pt) |
CA (1) | CA2392168C (pt) |
DE (1) | DE60010925T2 (pt) |
DK (1) | DK1235824T3 (pt) |
ES (1) | ES2222260T3 (pt) |
FR (1) | FR2801307B1 (pt) |
MX (1) | MXPA02005118A (pt) |
PL (1) | PL212711B1 (pt) |
PT (1) | PT1235824E (pt) |
RU (1) | RU2234503C2 (pt) |
WO (1) | WO2001038320A1 (pt) |
ZA (1) | ZA200203390B (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA04011903A (es) * | 2002-05-29 | 2005-03-31 | Lilly Co Eli | Moduladores de receptor de vitamina d tipo fenil-tiofeno. |
MXPA05002168A (es) * | 2002-08-27 | 2005-05-23 | Galderma Res & Dev | Analogos de vitamina d. |
CA2544517A1 (en) * | 2003-11-20 | 2005-06-09 | Eli Lilly And Company | Vitamin d receptor modulators |
DE602004008505T2 (de) | 2003-11-20 | 2008-05-21 | Eli Lilly And Co., Indianapolis | Modulatoren des vitamin-d-rezeptors |
US7579488B2 (en) * | 2003-11-20 | 2009-08-25 | Eli Lilly And Company | Vitamin D receptor modulators |
JP2007511578A (ja) | 2003-11-21 | 2007-05-10 | ガルデルマ・リサーチ・アンド・デヴェロップメント・エス・エヌ・セ | ビタミンdの投与のためのスプレー可能な組成物 |
CA2567099A1 (en) * | 2004-05-26 | 2005-12-08 | Cedars-Sinai Medical Center | Induction of innate immunity by vitamin d3 and its analogs |
PL1836151T3 (pl) * | 2004-12-21 | 2009-08-31 | Lilly Co Eli | Modulatory receptora witaminy D |
WO2009114540A2 (en) * | 2008-03-10 | 2009-09-17 | Wisconsin Alumni Research Foundation | Vitamin d compounds and methods for reducing ocular hypertension (oht) |
SG2014006324A (en) * | 2009-01-27 | 2014-03-28 | Berg Llc | Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy |
US8470304B2 (en) | 2009-08-04 | 2013-06-25 | Avidas Pharmaceuticals Llc | Therapeutic vitamin D sun-protecting formulations and methods for their use |
JP5978130B2 (ja) | 2009-08-14 | 2016-08-24 | バーグ エルエルシー | 脱毛症を治療するためのビタミンd3およびその類似体 |
US20120015913A1 (en) * | 2010-07-15 | 2012-01-19 | Delansorne Remi | Formulations of 14-EPI-Analogues of Vitamin D |
HUE044367T2 (hu) * | 2011-09-30 | 2019-10-28 | Allergan Pharmaceuticals Int Ltd | Elasztikus rostok in vivo szintézise |
CN105492081A (zh) | 2013-05-29 | 2016-04-13 | 博格有限责任公司 | 使用维生素d预防或减轻化疗诱发的脱发 |
CN107954927A (zh) * | 2017-10-30 | 2018-04-24 | 广东莱佛士制药技术有限公司 | 一种3-溴-5-(丙炔-1-基)吡啶的制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0507488A1 (en) * | 1991-03-27 | 1992-10-07 | Merck & Co. Inc. | Inhibitors of HIV-1 reverse transcriptase |
FR2741876B1 (fr) * | 1995-12-01 | 1998-01-09 | Cird Galderma | Composes biaromatiques portant un groupement adamantyl en para, compositions pharmaceutiques et cosmetiques les contenant et utilisations |
FR2746101B1 (fr) * | 1996-03-14 | 1998-04-30 | Composes bicycliques-aromatiques | |
FR2746098B1 (fr) * | 1996-03-14 | 1998-04-30 | Composes propynyl biaromatiques | |
FR2757852B1 (fr) * | 1996-12-31 | 1999-02-19 | Cird Galderma | Composes stilbeniques a groupement adamantyl, compositions les contenant et utilisations |
FR2759368B1 (fr) * | 1997-02-10 | 2001-06-01 | Galderma Rech Dermatologique | Composes biaromatiques, compositions les contenant et utilisations |
FR2785284B1 (fr) * | 1998-11-02 | 2000-12-01 | Galderma Res & Dev | Analogues de la vitamine d |
-
1999
- 1999-11-24 FR FR9914783A patent/FR2801307B1/fr not_active Expired - Fee Related
-
2000
- 2000-11-22 CA CA002392168A patent/CA2392168C/fr not_active Expired - Fee Related
- 2000-11-22 CN CNB008183783A patent/CN1214022C/zh not_active Expired - Fee Related
- 2000-11-22 AU AU21765/01A patent/AU767427B2/en not_active Ceased
- 2000-11-22 KR KR1020027006573A patent/KR100554555B1/ko not_active IP Right Cessation
- 2000-11-22 AT AT00985303T patent/ATE267190T1/de active
- 2000-11-22 DE DE60010925T patent/DE60010925T2/de not_active Expired - Lifetime
- 2000-11-22 MX MXPA02005118A patent/MXPA02005118A/es active IP Right Grant
- 2000-11-22 JP JP2001540083A patent/JP4003210B2/ja not_active Expired - Fee Related
- 2000-11-22 ES ES00985303T patent/ES2222260T3/es not_active Expired - Lifetime
- 2000-11-22 US US10/130,794 patent/US6706725B1/en not_active Expired - Fee Related
- 2000-11-22 WO PCT/FR2000/003250 patent/WO2001038320A1/fr not_active Application Discontinuation
- 2000-11-22 EP EP00985303A patent/EP1235824B1/fr not_active Expired - Lifetime
- 2000-11-22 PL PL355432A patent/PL212711B1/pl unknown
- 2000-11-22 RU RU2002116703/04A patent/RU2234503C2/ru not_active IP Right Cessation
- 2000-11-22 BR BRPI0015770-8B1A patent/BR0015770B1/pt not_active IP Right Cessation
- 2000-11-22 PT PT00985303T patent/PT1235824E/pt unknown
- 2000-11-22 DK DK00985303T patent/DK1235824T3/da active
- 2000-11-23 AR ARP000106192A patent/AR043280A1/es active IP Right Grant
-
2002
- 2002-04-29 ZA ZA200203390A patent/ZA200203390B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
FR2801307B1 (fr) | 2002-12-06 |
WO2001038320A1 (fr) | 2001-05-31 |
CN1423645A (zh) | 2003-06-11 |
ES2222260T3 (es) | 2005-02-01 |
CA2392168A1 (fr) | 2001-05-31 |
PT1235824E (pt) | 2004-10-29 |
BR0015770B1 (pt) | 2013-07-30 |
CN1214022C (zh) | 2005-08-10 |
FR2801307A1 (fr) | 2001-05-25 |
CA2392168C (fr) | 2008-01-22 |
JP4003210B2 (ja) | 2007-11-07 |
PL355432A1 (en) | 2004-04-19 |
AR043280A1 (es) | 2005-07-27 |
RU2234503C2 (ru) | 2004-08-20 |
DE60010925D1 (de) | 2004-06-24 |
ATE267190T1 (de) | 2004-06-15 |
EP1235824B1 (fr) | 2004-05-19 |
KR100554555B1 (ko) | 2006-03-03 |
MXPA02005118A (es) | 2003-01-28 |
KR20020069187A (ko) | 2002-08-29 |
AU767427B2 (en) | 2003-11-13 |
DE60010925T2 (de) | 2005-06-16 |
EP1235824A1 (fr) | 2002-09-04 |
ZA200203390B (en) | 2004-02-11 |
PL212711B1 (pl) | 2012-11-30 |
DK1235824T3 (da) | 2004-06-28 |
AU2176501A (en) | 2001-06-04 |
JP2004501059A (ja) | 2004-01-15 |
US6706725B1 (en) | 2004-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0015924A (pt) | Compostos triaromáticos análogos de vitamina d, uso de um composto, composição farmacêutica, composição cosmética e uso de uma composição cosmética | |
AR024516A1 (es) | Compuestos bi-aromaticos analogos de la vitamina d, su utilizacion, composicion farmaceutica y composicion cosmetica que comprenden al menos uno de dichos compuestos y utilizacion de dicha composicion cosmetica. | |
BR0015770A (pt) | Compostos bicìclicos análogos de vitamina d, uso de um composto, composição farmacêutica, composição cosmética e uso de uma composição cosmética | |
BR0113251A (pt) | Compostos, composição cosmética, composição farmacêutica, uso cosmético de uma composição e uso de um composto | |
BRPI0412526A (pt) | composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica | |
CY1109843T1 (el) | Αναλογα της βιταμινης d | |
DE69718734T2 (de) | Bicyclisch-aromatische Verbindungen | |
AU7023987A (en) | Pharmaceutical compositions containing propylene glycol and/or polyethylene glycol and urea as active main components and use thereof | |
CA2396186A1 (en) | Agents for the treatment of skin disorders | |
BRPI0411674A (pt) | compostos, composição cosmética, uso cosmético de uma composição, uso de um composto, composição farmacêutica, e processo cosmético para o embelezamento da pele | |
BR9702074A (pt) | Compostos biaril heterocíclicos composições farmacêuticas e cosméticas que os contêm e suas utilizações | |
BRPI0411503A (pt) | composto, composição farmacêutica, uso de um composto, método de tratar um ser humano que sofre de uma doença hiperproliferativa tal como cáncer, e, processo para a preparação de um composto | |
HUP0100539A2 (hu) | D-vitamint és kálciumot tartalmazó gyógyászati készítmények és eljárás azok előállítására | |
ATE322878T1 (de) | Biotin enthaltende galenische formulierung | |
AR005860A1 (es) | Compuestos heterociclicos aromaticos, composiciones farmaceuticas y cosmeticas que los contienen, y su utilización. | |
FR2746098B1 (fr) | Composes propynyl biaromatiques | |
BR0010983A (pt) | Preparações para a aplicação de agentes antiinflamatórios | |
AR001354A1 (es) | Compuestos bi-aromaticos derivados de amida, composiciones farmacéuticas y cosméticas que los contien, y utilización de dichos compuestos y composición cosmética. | |
BR0215124A (pt) | Compostos e seus usos, composições farmacêutica e cosmética e uso cosmético de uma composição cosmética | |
BR0316193A (pt) | Composto, composição cosmética, uso cosmético de uma composição, uso de um composto e composição farmacêutica | |
BR9708297A (pt) | Compostos composição farmacéutica cosmposição e uso de uma composição cosmética | |
ES2184424T3 (es) | Nuevos compuestos heteroetinilenos y composiciones farmaceuticas y cosmeticas que los contienen. | |
BR9911833A (pt) | Compostos diaril selenetos, composição farmacêutica, cosmética e sua utilização em medicina humana e veterinária, bem como em cosmetologia | |
ATE298256T1 (de) | Biomaterial in form von mikropartikeln von hyaluronsaure zur medizinischen verwendung | |
BR0312318A (pt) | Compostos, uso de um ou mais compostos, composição farmacêutica, composição cosmética e usos cosméticos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] |
Free format text: DE ACORDO COM ART. 34 " II " DA LPI ( LEI 9279, DE 14/05/96 ) , O EXAME FICA SUSPENSO PARA QUE O REQUERENTE APRESENTE DOCUMENTOS NECESSARIOS A REGULARIZACAO DO PROCESSO E EXAME DO PEDIDO. |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI. |
|
B07C | Technical examination (opinion): republication [chapter 7.3 patent gazette] |
Free format text: REPUBLICACAO QUANTO AO TEXTO DO DESPACHO 7.5 PUBLICADO NA RPI 2206 DE 16/04/2013. LEIA-SE O CORRETO: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI. |
|
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 30/07/2013, OBSERVADAS AS CONDICOES LEGAIS. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 16A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2386 DE 27-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
B15K | Others concerning applications: alteration of classification |
Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: C07D 333/16; C07D 213/30; A61K 31/44; A61K 31/381; A61K 7/48; A61P 17/00. Ipc: A61Q 19/00 (2006.01), A61K 8/67 (2006.01), A61Q 5/ Ipc: A61Q 19/00 (2006.01), A61K 8/67 (2006.01), A61Q 5/ |